Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
Auranen A, Powell MA, Sukhin V, Landrum LM, Ronzino G, Buscema J, Bauerschlag D, Lalisang R, Bender D, Gilbert L, Armstrong A, Safra T, Nevadunsky N, Sebastianelli A, Slomovitz B, Ring K, Coleman R, Podzielinski I, Stuckey A, Teneriello M, Gill S, Pothuri B, Willmott L, Sharma S, Dabrowski C, Antony G, Stevens S, Mirza MR, Fleming E. Auranen A, et al. Among authors: sebastianelli a. Ther Adv Med Oncol. 2024 Sep 28;16:17588359241277656. doi: 10.1177/17588359241277656. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39346117 Free PMC article.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972026 Clinical Trial.
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.
Powell MA, Bjørge L, Willmott L, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Gropp-Meier M, Stuckey A, Boere I, Gold MA, Segev Y, Gill SE, Gennigens C, Sebastianelli A, Shahin MS, Pothuri B, Monk BJ, Buscema J, Coleman RL, Slomovitz BM, Ring KL, Herzog TJ, Balas MM, Grimshaw M, Stevens S, Lai DW, McCourt C, Mirza MR. Powell MA, et al. Among authors: sebastianelli a. Ann Oncol. 2024 Aug;35(8):728-738. doi: 10.1016/j.annonc.2024.05.546. Epub 2024 Jun 10. Ann Oncol. 2024. PMID: 38866180 Free article. Clinical Trial.
Global distribution and career outcomes of international fellows trained in Canadian gynecologic oncology programs.
Touhami O, De Guerke L, Teo Fortin LA, Foo J, Provencher D, Samouelian V, Cormier B, Lau S, Salvador S, Gotlieb W, Gilbert L, Laframboise S, Altman AD, Ghatage P, Brar H, Kwon J, Le T, Sebastianelli A, Fokom Domgue J, Plante M. Touhami O, et al. Among authors: sebastianelli a. Gynecol Oncol Rep. 2024 Sep 16;56:101512. doi: 10.1016/j.gore.2024.101512. eCollection 2024 Dec. Gynecol Oncol Rep. 2024. PMID: 39386924 Free PMC article.
Patient-reported Outcome Measures and Experience Measures After Active Surveillance Versus Radiation Therapy Versus Radical Prostatectomy for Prostate Cancer: A Systematic Review of Prospective Comparative Studies.
Alberti A, Nicoletti R, Castellani D, Yuan Y, Maggi M, Dibilio E, Resta GR, Makrides P, Sessa F, Sebastianelli A, Serni S, Gacci M, De Nunzio C, Teoh JYC, Campi R. Alberti A, et al. Among authors: sebastianelli a. Eur Urol Oncol. 2024 Dec;7(6):1255-1266. doi: 10.1016/j.euo.2024.05.008. Epub 2024 May 29. Eur Urol Oncol. 2024. PMID: 38816298 Free article. Review.
Hyperglycemia and microRNAs in prostate cancer.
Russo V, Tamburrino L, Morselli S, Sani C, Baldi E, Sebastianelli A, Raspollini MR, Mongia A, Carradori V, Lallo E, Munnia A, Bisanzi S, Marchiani S, Visioli C, Rapi S, Serni S, Zappa M, Carozzi F, Peluso M. Russo V, et al. Among authors: sebastianelli a. Prostate Cancer Prostatic Dis. 2024 Feb 24. doi: 10.1038/s41391-024-00809-z. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38402304
A reproducible ensemble machine learning approach to forecast dengue outbreaks.
Sebastianelli A, Spiller D, Carmo R, Wheeler J, Nowakowski A, Jacobson LV, Kim D, Barlevi H, Cordero ZER, Colón-González FJ, Lowe R, Ullo SL, Schneider R. Sebastianelli A, et al. Sci Rep. 2024 Feb 15;14(1):3807. doi: 10.1038/s41598-024-52796-9. Sci Rep. 2024. PMID: 38360915 Free PMC article.
Impact of minimally invasive surgical procedures for Male Lower Urinary Tract Symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review.
Gemma L, Pecoraro A, Sebastianelli A, Spatafora P, Sessa F, Nicoletti R, Gravas S, Campi R, Serni S, Gacci M. Gemma L, et al. Among authors: sebastianelli a. Prostate Cancer Prostatic Dis. 2024 Sep;27(3):404-421. doi: 10.1038/s41391-024-00795-2. Epub 2024 Feb 14. Prostate Cancer Prostatic Dis. 2024. PMID: 38355729 Review.
Morbidity of Transrectal MRI-Fusion Targeted Prostate Biopsy at a Tertiary Referral Academic Centre: An Audit to Guide the Transition to the Transperineal Approach.
Alberti A, Nicoletti R, Polverino P, Rivetti A, Dibilio E, Resta GR, Makrides P, Caneschi C, Cifarelli A, D'Amico A, Moscardi L, Lo Re M, Peschiera F, Gallo ML, Pecoraro A, Sebastianelli A, Masieri L, Gacci M, Serni S, Campi R, Sessa F. Alberti A, et al. Among authors: sebastianelli a. Cancers (Basel). 2023 Dec 11;15(24):5798. doi: 10.3390/cancers15245798. Cancers (Basel). 2023. PMID: 38136344 Free PMC article.
130 results